VEGFA and neoplasm: Some hypothesize, quite cogently that as tumours secrete multiple pro-angiogenic molecules (FGFs, IL8, Dll4, PlGF, Ang and so on), targeting only the VEGF signalling axis may explain the lower-than-expected efficacy in the clinic40.